About X4 Pharmaceuticals, Inc. - Common Stock (XFOR)
X4 Pharmaceuticals Inc is a biotechnology company focused on developing innovative therapies for rare diseases and conditions, particularly those related to immune system dysfunction. The company is dedicated to advancing its proprietary drug candidates aimed at treating a range of serious health issues, including genetic disorders and certain cancers. By leveraging its expertise in cell biology and drug discovery, X4 Pharmaceuticals is committed to addressing unmet medical needs through the creation of targeted and effective treatments, enhancing patient outcomes and quality of life. Read More
The company said that the originally announced offering of $60 million was increased to $85 million to allow for the inclusion of an investor who had a pre-existing investment right.
Low-priced momentum plays are heating up the tape as earnings beats, insider buys, and strategic deals fuel speculation ahead of key catalysts. From crypto-backed balance sheets to mass retail expansion and sustainable technology breakthroughs, these sub-$5 companies are lining up for potential breakout runs. Traders scanning for under-the-radar opportunities may find this week’s lineup too hot to ignore.
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.
